Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM)

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 527-529

  Agius, Mark A ^a   Zhu, Shan ^a   Fairclough, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; AUTOANTIBODY; HAPTEN; PROCAINAMIDE; RAPSYN;

AGED; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUPUS ERYTHEMATOSUS; MALE; MYOPATHY; SERODIAGNOSIS;

EID: 0031927908     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10975.x     Document Type: Conference Paper

References (3)

1. BLANCHARD, S. G. & M. A. RAFTERY. 1979. Identification of the polypeptide chains in Torpedo californica electroplax membranes that interact with a local anesthetic analog. Proc. Natl. Acad. Sci. U.S.A. 76: 81-85.
2. LEE, D. C., Y. I. KIM, H. H. LIU & T. R. JOHNS. 1983. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission. Muscle Nerve 6: 442-441.
3. MILLER, C. D., M. A. OLESHANSKY, K. F. GIBSON & L. R. CANTILENA. 1993. Case report: procainamide-induced myasthenia-Iike weakness and dysphagia. Ther. Drug Monit. 15: 251-254.